Our study further demonstrated that by inhibiting IL-1β production in the brain, neurodevelopment could be improved, which indicated that IL-1β could be a potential therapeutic target against neurodevelopment impairment caused by neonatal sepsis [20]. This evidence concerns the gene IL1B and Neonatal sepsis.